Change 5-day change 1-year change 3-year change Capi.($)
-9.09%-9.09% - - 3.03Cr
+0.21%-2.69%+1.19%+17.32% 4.97TCr
+2.09%-0.71%+452.73%+498.77% 4.5TCr
-1.09%-0.41%+35.40%+15.17% 4.25TCr
-0.26%-4.71%+17.19%+71.67% 4.08TCr
-0.48%-0.84%+16.25%+49.80% 3.29TCr
-1.06%+2.87% - - 1.71TCr
-1.81%-5.02%+22.65%+113.24% 1.63TCr
-1.35%-3.40%+10.13%+26.34% 1.44TCr
-2.05%-5.14%+72.89%+34.69% 1.35TCr
Average -1.65%-2.44%+78.55%+103.38% 3.02TCr
Weighted average by Cap. -0.50%-2.27%+96.69%+122.29%
Logo Ophthalix Inc
Wize Pharma Inc, formerly Ophthalix, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the treatment of ophthalmic disorders, including dry eye syndrome (DES) and other inflammatory conditions. The Company markets, sells and distributes a formula known as LO2A, which protects ocular surface tissues. LO2A is a drug developed for the treatment of DES and other ophthalmological illnesses, including conjunctivochalasis (CCH) and sjogren's syndrome (sjogren's).
Employees
-